Public Law 115-97 (formerly known as H.R. 1, Tax Cuts and Jobs Act) Implementation to provide for reconciliation pursuant to titles II and V of the concurrent resolution on the budget for fiscal year 2018 
Draft legislation relating to economic activity in Puerto Rico
International tax issues, including OECD digital taxation work program H.R. 1499, Protecting Consumer Access to Generic Drugs Act of 2019 - Provisions related to patent settlements
H.R. 3991, Affordable Prescriptions for Patients Through Improvements to Patent Litigation Act of 2019
H.R. 4398, Affordable Prescriptions for Patients Through Promoting Competition Act of 2019
H.R. 5133, Affordable Prescriptions for Patients Through Promoting Competition Act of 2019
Biopharmaceutical innovation and patent policy issues
S. 1416, Affordable Prescriptions for Patients Act of 2019 - Provisions related to prescription drug patents
Patent litigation reform issues and issues related to post-grant proceeding at the PTO
Value of intellectual property 
Patent protection H.R. 3, Lower Drug Costs Now Act of 2019 - Provisions related to non-interference, International Pricing Index Model and Medicare Part D 
H.R. 19, Lower Costs, More Cures Act of 2019 - Provisions related to Medicare Part D and prescription drug pricing 
H.R. 1506, Fair and Immediate Release of (FAIR) Generic Drugs Act - Provisions related to generic prescription drug approvals
H.R. 2113, Prescription Drug STAR Act - Provisions related to transparency of prescription drug pricing
S. 474, Stopping the Pharmaceutical Industry from Keeping drugs Expensive (SPIKE) Act of 2019
S.1895, Lower Health Care Costs Act - Provisions related to prescription drug pricing, transparency and patent issues
340B drug discount program policy issues
Drug cost and pricing policy issues
Transparency policy issues
Patient affordability issues H.R. 107, To amend title XIX of the Social Security Act to sunset the limit on the maximum rebate amount for single source drugs and innovator multiple source drugs.
H.R. 1046, Medicare Negotiation and Competitive Licensing Act of 2019 - Provisions related to Medicare Part D, drug pricing negotiation and march-in rights
S. 475, RxCAP Act of 2019 - Provisions related to Part D and patient cost-sharing
Department of Health and Human Services (HHS) drug policy issues and regulatory policy issues
Part D policy issues including non-interference, out of pocket cap and rebates policy issues
S. 2543, Prescription Drug Pricing Reduction Act of 2019 - Provisions related to Medicare Part D, Medicaid, and drug pricing
S. 2911, Seniors Prescription Drug Relief Act of 2019 - Provisions related to Medicare Part D
Medicaid policy issues including rebates policy and average manufacture price (AMP) caps
CMS Advanced Notice of Proposed Rulemaking on International Pricing Index Model for Medicare Part B Drugs USMCA and related policy issues H.R. 2740, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Bill 2020 - HHS provisions related to prescription drugs
FY 2020 Omnibus Appropriations Bill - Provisions relating to biopharmaceutical products
TAX - Taxation/Internal Revenue Code CPT - Copyright/Patent/Trademark HCR - Health Issues MMM - Medicare/Medicaid TRD - Trade (domestic/foreign) BUD - Budget/Appropriations
14 - Council of Economic Advisers (CEA) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 14 - Council of Economic Advisers (CEA) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 14 - Council of Economic Advisers (CEA) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 14 - Council of Economic Advisers (CEA) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 14 - Council of Economic Advisers (CEA) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 14 - Council of Economic Advisers (CEA) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
ABBVIE, INC.
1399 New York Avenue NW, Suite 600, Washington, DC, 20005, US
DANIEL BACHNER STEPHEN SCANGO DANIEL BACHNER STEPHEN SCANGO BINTA BEARD STEPHEN SCANGO DANIEL BACHNER BINTA BEARD STEPHEN SCANGO DANIEL BACHNER BINTA BEARD DANIEL BACHNER STEPHEN SCANGO BINTA BEARD DANIEL BACHNER STEPHEN SCANGO